Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial inner membrane proton gradient is a fundamental electrochemical gradient established across the inner mitochondrial membrane during cellular respiration. It is essential for ATP synthesis in eukaryotic cells and underpins the process of oxidative phosphorylation. The gradient is generated by the electron transport chain (ETC), which pumps protons (H⁺) from the mitochondrial matrix into the intermembrane space, creating a pH gradient and a voltage gradient. This proton-motive force drives protons back into the matrix through ATP synthase, catalyzing ATP production. Disruption or uncoupling of this proton gradient impairs cellular energy production and can contribute to metabolic diseases or cell death. Modulation of proton leak is explored as a therapeutic avenue for various diseases.
Proton gradient drives ATP synthesis via ATP synthase; uncoupling agents dissipate the gradient.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Inner Membrane Proton Gradient (PMF).